These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 30342173)

  • 1. Combination drug therapy via nanocarriers against infectious diseases.
    Walvekar P; Gannimani R; Govender T
    Eur J Pharm Sci; 2019 Jan; 127():121-141. PubMed ID: 30342173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nano-carriers for the Treatment of Tuberculosis.
    Gilani SJ; Ameeduzzafar ; Jafar M; Shakil K; Imam SS
    Recent Pat Antiinfect Drug Discov; 2017; 12(2):95-106. PubMed ID: 28595544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biodegradable nanoparticles for intracellular delivery of antimicrobial agents.
    Xie S; Tao Y; Pan Y; Qu W; Cheng G; Huang L; Chen D; Wang X; Liu Z; Yuan Z
    J Control Release; 2014 Aug; 187():101-17. PubMed ID: 24878179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An oral formulation of efavirenz-loaded lactoferrin nanoparticles with improved biodistribution and pharmacokinetic profile.
    Kumar P; Lakshmi YS; Kondapi AK
    HIV Med; 2017 Aug; 18(7):452-462. PubMed ID: 28000390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Solid nanoparticles for oral antimicrobial drug delivery: a review.
    Raza A; Sime FB; Cabot PJ; Maqbool F; Roberts JA; Falconer JR
    Drug Discov Today; 2019 Mar; 24(3):858-866. PubMed ID: 30654055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanodelivery systems for improved topical antimicrobial therapy.
    Basnet P; Škalko-Basnet N
    Curr Pharm Des; 2013; 19(41):7237-43. PubMed ID: 23489202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pulmonary drug delivery: a review on nanocarriers for antibacterial chemotherapy.
    Moreno-Sastre M; Pastor M; Salomon CJ; Esquisabel A; Pedraz JL
    J Antimicrob Chemother; 2015 Nov; 70(11):2945-55. PubMed ID: 26203182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insights on Oral Drug Delivery of Lipid Nanocarriers: a Win-Win Solution for Augmenting Bioavailability of Antiretroviral Drugs.
    Nabi B; Rehman S; Baboota S; Ali J
    AAPS PharmSciTech; 2019 Jan; 20(2):60. PubMed ID: 30623263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanoengineered drug delivery systems for enhancing antibiotic therapy.
    Kalhapure RS; Suleman N; Mocktar C; Seedat N; Govender T
    J Pharm Sci; 2015 Mar; 104(3):872-905. PubMed ID: 25546108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nano-fats for bugs: the benefits of lipid nanoparticles for antimicrobial therapy.
    Thorn CR; Thomas N; Boyd BJ; Prestidge CA
    Drug Deliv Transl Res; 2021 Aug; 11(4):1598-1624. PubMed ID: 33675007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanoparticle-Based ARV Drug Combinations for Synergistic Inhibition of Cell-Free and Cell-Cell HIV Transmission.
    Jiang Y; Cao S; Bright DK; Bever AM; Blakney AK; Suydam IT; Woodrow KA
    Mol Pharm; 2015 Dec; 12(12):4363-74. PubMed ID: 26529558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How nanotechnology-enabled concepts could contribute to the prevention, diagnosis and therapy of bacterial infections.
    Herrmann IK
    Crit Care; 2015 May; 19(1):239. PubMed ID: 26025027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combinatorial nanocarriers against drug resistance in hematological cancers: Opportunities and emerging strategies.
    Ghosh S; Lalani R; Patel V; Bardoliwala D; Maiti K; Banerjee S; Bhowmick S; Misra A
    J Control Release; 2019 Feb; 296():114-139. PubMed ID: 30664978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipid-Based Nanocarriers for Cutaneous Leishmaniais and Buruli Ulcer Management.
    Simoes S; Carvalheiro M; Gaspar MM
    Curr Pharm Des; 2016; 22(43):6577-6586. PubMed ID: 27396598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipid-polymer hybrid nanocarriers for delivering cancer therapeutics.
    Date T; Nimbalkar V; Kamat J; Mittal A; Mahato RI; Chitkara D
    J Control Release; 2018 Feb; 271():60-73. PubMed ID: 29273320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antimicrobial lipids in nano-carriers for antibacterial delivery.
    Zhang Q; Wu W; Zhang J; Xia X
    J Drug Target; 2020 Mar; 28(3):271-281. PubMed ID: 31613147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nano-based drug delivery optimization for tuberculosis treatment: A review.
    Dahanayake MH; Jayasundera ACA
    J Microbiol Methods; 2021 Feb; 181():106127. PubMed ID: 33359155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ratiometric drug delivery using non-liposomal nanocarriers as an approach to increase efficacy and safety of combination chemotherapy.
    Franco MS; Oliveira MC
    Biomed Pharmacother; 2017 Dec; 96():584-595. PubMed ID: 29035823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biodegradable chitosan nanoparticles in drug delivery for infectious disease.
    Landriscina A; Rosen J; Friedman AJ
    Nanomedicine (Lond); 2015 May; 10(10):1609-19. PubMed ID: 26008195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.